Systemic therapy treatment patterns in patients with advanced non-small cell lung cancer (NSCLC): PIvOTAL study-Reference-Cited by-同舟云学术

Systemic therapy treatment patterns in patients with advanced non-small cell lung cancer (NSCLC): PIvOTAL study

Published:2017-07-27 Issue:6 Volume:26 Page:e12734
ISSN:0961-5423
Container-title:European Journal of Cancer Care
language:en
Short-container-title:Eur J Cancer Care

Author:

de Castro J.¹,Tagliaferri P.²³,de Lima V.C.C.⁴,Ng S.⁵,Thomas M.⁶,Arunachalam A.⁷,Cao X.⁷,Kothari S.⁷,Burke T.⁷,Myeong H.⁸,Grattan A.⁹,Lee D.H.¹⁰

Affiliation:

1. Medical Oncology Service; Hospital Universitario La Paz (IDIPAZ); Madrid Spain

2. Azienda Ospedaliero Universitaria Mater Domini; Catanzaro Italy

3. Dipartimento di Medicina Sperimentale e Clinica; Magna Graecia University; Catanzaro Italy

4. Department of Medical Oncology; A. C. Camargo Cancer Center; São Paulo Brazil

5. Bendigo Cancer Centre; Bendigo Health; Bendigo Vic. Australia

6. Internistische Onkologie der Thoraxtumoren; Thoraxklinik im Universitätsklinikum Heidelberg; Translational Lung Research Center Heidelberg (TLRC-H); Member of the German Center for Lung Research (DZL); Heidelberg Germany

7. Center for Observational and Real World Evidence (CORE); Merck & Co., Inc.; Rahway NJ USA

8. Oncology Global Medical Affairs; MSD Korea; Seoul Korea

9. MSD Australia; Macquarie Park NSW Australia

10. Department of Oncology; University of Ulsan College of Medicine; Asan Medical Center; Seoul Korea

Funder

Merck

Publisher

Wiley

Subject

Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ecc.12734/fullpdf

Reference36 articles.

1. Survival and prognostic factors in patients with non-small cell lung cancer treated in private health care;Araujo;Revista Brasileira de Epidemiologia,2014

2. 2nd ESMO consensus conference on lung cancer: Non-small-cell lung cancer first-line/second and further lines of treatment in advanced disease;Besse;Annals of Oncology,2014

3. Observation of the treatment and outcomes of patients receiving chemotherapy for advanced NSCLC in Europe (ACTION study);Bischoff;Current Medical Research and Opinion,2010

4. Karnofsky and ECOG performance status scoring in lung cancer: A prospective, longitudinal study of 536 patients from a single institution;Buccheri;European Journal of Cancer,1996

5. Clinical management patterns and treatment outcomes in patients with non-small cell lung cancer (NSCLC) across Europe: EPICLIN-Lung study;Carrato;Current Medical Research and Opinion,2014

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of lung adenocarcinoma subtypes on survival and timing of brain metastases;Frontiers in Oncology;2024-09-03

2. Primary pulmonary enteric adenocarcinoma presenting as a solitary skull mass;BMJ Case Reports;2024-01

3. The journey of stage III and IV non-small cell lung cancer patients in the Brazilian private healthcare system: a retrospective study;Frontiers in Oncology;2023-10-18

4. The Multiple Faces of Lung Adenocarcinoma: Challenges in Diagnosis;Internal Medicine;2023-10-01

5. Effectiveness and safety of Shenqi Fuzheng injection combined with platinum-based chemotherapy for treatment of advanced non-small cell lung cancer: a systematic review and meta-analysis;Frontiers in Oncology;2023-08-24